| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
41,630,000 |
| Market
Cap: |
26.95(M) |
| Last
Volume: |
204,752 |
Avg
Vol: |
427,496 |
| 52
Week Range: |
$0.6474 - $0.6474 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Lannett primarily develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. Co.'s primary products include: Amphetamine IR Tablets, which are used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy; Amphetamine ER Capsules, which are indicated for use to treat ADHD; Dicyclomine Tablets, which are indication for the treatment of functional bowel disorder and irritable bowel syndrome; Fluphenazine Tablets, which are used for the management of manifestations of psychotic disorders; and Levothyroxine Capsules, which are soft gel capsules used to treat patients with hypothyroidism and other conditions.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
216,159 |
| Total Buy Value |
$0 |
$0 |
$0 |
$108,668 |
| Total People Bought |
0 |
0 |
0 |
4 |
| Total Buy Transactions |
0 |
0 |
0 |
5 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Galvan Martin P |
VP of Finance & CFO |
• – – |
2018-07-27 |
4 |
D |
$12.55 |
$2,096 |
D/D |
(167) |
38,343 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2018-07-27 |
4 |
D |
$12.55 |
$1,330 |
D/D |
(106) |
12,940 |
|
- |
|
| Kozlowski John |
Chief Operating Officer |
• – – |
2018-07-27 |
4 |
D |
$12.55 |
$1,531 |
D/D |
(122) |
17,308 |
|
- |
|
| Landis G. Michael |
Principal Accounting Officer |
• – – |
2018-07-22 |
4 |
D |
$12.35 |
$1,754 |
D/D |
(142) |
5,056 |
|
- |
|
| Ehlinger Robert |
VP and CIO |
• – – |
2018-07-22 |
4 |
D |
$12.35 |
$4,384 |
D/D |
(355) |
23,807 |
|
- |
|
| Galvan Martin P |
VP of Finance & CFO |
• – – |
2018-07-22 |
4 |
D |
$12.35 |
$5,162 |
D/D |
(418) |
38,510 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2018-07-22 |
4 |
D |
$12.35 |
$1,112 |
D/D |
(90) |
13,046 |
|
- |
|
| Kozlowski John |
Chief Operating Officer |
• – – |
2018-07-22 |
4 |
D |
$12.35 |
$1,494 |
D/D |
(121) |
17,430 |
|
- |
|
| Farber Jeffrey |
Director |
– • – |
2018-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
16,195 |
2,076,054 |
|
- |
|
| Lepore Patrick G |
Director |
– • – |
2018-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
16,195 |
42,895 |
|
- |
|
| Paonessa Albert Iii |
Director |
– • – |
2018-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
16,195 |
30,277 |
|
- |
|
| Taveira Paul |
Director |
– • – |
2018-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
16,195 |
47,970 |
|
- |
|
| Maher James M. |
Director |
– • – |
2018-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
16,195 |
43,492 |
|
- |
|
| Drabik David A |
Director |
– • – |
2018-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
18,195 |
49,747 |
|
- |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2018-07-15 |
4 |
D |
$13.60 |
$25,949 |
D/D |
(1,908) |
17,711 |
|
- |
|
| Kozlowski John |
Chief Operating Officer |
• – – |
2018-07-11 |
4 |
D |
$14.50 |
$6,569 |
D/D |
(453) |
17,551 |
|
- |
|
| Landis G. Michael |
Principal Accounting Officer |
• – – |
2018-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,234 |
8,432 |
|
- |
|
| Crew Timothy C |
Chief Executive Officer |
• – – |
2018-06-30 |
4 |
A |
$11.56 |
$7,907 |
D/D |
684 |
38,934 |
|
- |
|
| Ehlinger Robert |
VP and CIO |
• – – |
2018-06-30 |
4 |
A |
$11.56 |
$7,549 |
D/D |
653 |
24,162 |
|
- |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2018-06-30 |
4 |
A |
$11.56 |
$4,300 |
D/D |
372 |
19,619 |
|
- |
|
| Smith Kevin |
Senior VP of Sales |
• – – |
2018-06-14 |
4 |
S |
$16.51 |
$192,622 |
D/D |
(11,667) |
18,458 |
|
- |
|
| Smith Kevin |
Senior VP of Sales |
• – – |
2018-06-14 |
4 |
OE |
$4.16 |
$48,535 |
D/D |
11,667 |
30,125 |
|
- |
|
| Lepore Patrick G |
Director |
– • – |
2018-05-11 |
4 |
B |
$15.13 |
$378,250 |
D/D |
25,000 |
26,700 |
2.39 |
- |
|
| Crew Timothy C |
Chief Executive Officer |
• – – |
2018-05-10 |
4 |
AB |
$14.73 |
$29,460 |
D/D |
2,000 |
18,914 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2018-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,193 |
13,136 |
|
- |
|
762 Records found
|
|
Page 10 of 31 |
|
|
